Ep 189 [24 September 2025]: Ivana Naeymi-Rad MS, COO at IMO Health – Pharma and health tech companies don’t suffer from a lack of data; they suffer from a lack of clarity as clinical insights are buried under billing codes, unstructured notes, and inconsistent language that distort intent. Manual reviews and mapping struggle to keep pace, leading to gaps, noise, and lost reproducibility and endpoints. Ivana shared why normalization and IMO Health’s terminology is the essential companion to all real-world data, ensuring clinical intent is preserved, transforming costly RWD investments into insights and evidence you can trust.
Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club
Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.